Please login to the form below

Not currently logged in


This page shows the latest ivacaftor news and features for those working in and with pharma, biotech and healthcare.

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

It maintains that it has offered a bundle deal for Kalydeco (ivacaftor), Orkambi (lumacaftor/ivacaftor), experimental combination tezacaftor/ivacaftor – as well as other CF therapies in development – that provides “budget certainty

Latest news

More from news
Approximately 6 fully matching, plus 20 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare through effective collaboration. Making work to feel proud of.

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....